Q1 2017 Genocea Biosciences Inc Earnings Call

4/5/2017 9:00

Conference Call Genocea Biosciences Inc

Genocea Biosciences Inc Conference call will be held on May 4, 2017. During the earnings conference call's session Genocea Biosciences Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Genocea Biosciences Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
Unless the context requires otherwise, references in this Annual Report on Form 10-K to "Genocea", "we", "us" and "our" refer to Genocea Biosciences, Inc. Overview We are a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies to address diseases with significant unmet needs. We use our proprietary discovery platform, ATLASTM, to rapidly design vaccines and immunotherapies that act, in part, through T cell (or cellular) immune responses, in contrast to approved vaccines and immunotherapies, which are designed to act primarily through B cell (or antibody) immune responses. We believe that by harnessing T cells we can develop first-in-class vaccines and immunotherapies to address diseases where T cells are central to the control of the disease. We have one product candidate in active Phase 2 clinical development, GEN-003, an immunotherapy for the treatment of genital herpes.    
Read more Conference Call

Genocea Biosciences Inc (GNCA)

Cambridge Discovery Park, Cambridge Massachusetts 02140, United States